<?xml version="1.0" encoding="UTF-8"?>
<supplementary-material content-type="local-data" id="jcsm12316-supitem-0001">
 <caption>
  <p>
   <bold>Fig. S1.</bold> Visual Analogue Scale pain score adjusted mean change from baseline.
  </p>
  <p>
   <bold>Figure S2.</bold> Harris hip score adjusted mean change from baseline—mITT.
  </p>
  <p>
   <bold>Figure S3.</bold> Quality of Life (SF36) physical scores adjusted mean change from baseline—mITT.
  </p>
  <p>
   <bold>Figure S4.</bold> Quality of Life (SF36) mental scores adjusted mean change from baseline—mITT.
  </p>
  <p>
   <bold>Figure S5.</bold> Total IL‐8 (pg/mL).
  </p>
  <p>
   <bold>Figure S6.</bold> TNF‐alpha (pg/mL).
  </p>
  <p>
   <bold>Figure S7.</bold> VEGF (pg/mL).
  </p>
  <p>
   <bold>Figure S8.</bold> IL1‐RA (pg/mL).
  </p>
  <p>
   <bold>Figure S9.</bold> sE‐Selectin (ng/mL).
  </p>
  <p>
   <bold>Figure S10.</bold> sVCAM (ng/mL).
  </p>
  <p>
   <bold>Figure S11.</bold> sICAM (ng/mL).
  </p>
  <p>
   <bold>Figure S12.</bold> Activated B‐cells (in % CD19+) adjusted mean change from baseline—mITT.
  </p>
  <p>
   <bold>Figure S13.</bold> CD 57+ TEMRA (in % of CD 8+ cells) adjusted mean change from baseline—mITT.
  </p>
  <p>
   <bold>Figure S14.</bold> Total T‐regulatory cells/nL adjusted mean change from baseline—mITT.
  </p>
  <p>
   <bold>Figure S15.</bold> Myeloid DC2 (CD11 + BDCA3‐)/nL adjusted mean change from baseline—mITT.
  </p>
  <p>
   <bold>Table S1.</bold> Schedule of events.
  </p>
  <p>
   <bold>Table S2.</bold> Concomitant medication (reported in ≥4 patients) by treatment group.
  </p>
  <p>
   <bold>Table S3.</bold> Overview of treatment‐emergent adverse events by treatment group.
  </p>
  <p>
   <bold>Table S4.</bold> Frequency and incidence of treatment‐emergent adverse events by MedDRA preferred term and by treatment group.
  </p>
 </caption>
 <media xlink:href="JCSM-9-880-s001.docx" xmlns:xlink="http://www.w3.org/1999/xlink">
  <caption>
   <p>Click here for additional data file.</p>
  </caption>
 </media>
</supplementary-material>
